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OBJECTIVES This study evaluated the feasibility, pertinence and psychosocial repercussions of a noninva-
sive reduced hospital stay strategy (three days) for low-risk patients with acute myocardial
infarction using simple clinical criteria and predischarge 24-h ambulatory ST-segment
ischemic monitoring.
BACKGROUND Previous studies evaluating shorter stays for uncomplicated myocardial infarction have been
limited by retrospective or nonrandomized design and overdependence on invasive cardiac
procedures.
METHODS One-hundred twenty consecutive patients admitted with an acute myocardial infarction
fulfilling low-risk criteria were randomized 2:1 to a short hospital stay (80 patients) or
standard stay (40 patients). Short-stay patients with no ischemia on ST-segment monitoring
were discharged on day 3, returning for exercise testing a week later. All analyses were on an
intention-to-treat basis.
RESULTS Forty-one percent of all screened patients with acute myocardial infarction would have been
medically eligible for the short-stay strategy. Seventeen patients (21%) were not discharged
early because of ischemia on ST-monitoring or angina. Median initial hospital stay was
halved from 6.9 days in the standard stay to 3.5 days in the short-stay group. At six months,
median total days hospitalized were 7.5 in the standard stay and 3.6 in the short-stay group
(p , 0.0001). Adverse events and readmissions were low and not significantly different, and
there were 25% fewer invasive cardiac procedures in the short-stay group. Psychosocial
outcomes, risk factor changes and exercise test results were similar in the two groups.
CONCLUSIONS This reduced hospital stay strategy for low-risk patients with acute myocardial infarction is
feasible and worthwhile, resulting in a substantial and sustained reduction in days hospital-
ized. It is without unfavorable psychosocial consequences, appears safe and does not increase
the number of invasive cardiac procedures. (J Am Coll Cardiol 2001;37:1289–96) © 2001 by
the American College of Cardiology
The average hospital stay for patients with an acute myo-
cardial infarction (MI) has decreased from four to six weeks
30 years ago to two to three weeks 20 years ago, and is
currently six to 10 days (1–7). Such patients are now
generally observed over four to seven days, and in the
absence of cardiac failure, severe arrhythmias or myocardial
ischemia they are progressively mobilized while intravenous
medications such as nitroglycerin and heparin are ceased.
Usually, asymptomatic patients then undergo noninvasive
evaluation with a simple exercise test or myocardial imaging
with exercise, pharmacologic vasodilation or stress echocar-
diography and are generally discharged if results are favor-
able. If noninvasive testing suggests important residual
ischemia or if there is refractory or spontaneous postinfarc-
tion angina, patients usually undergo coronary arteriography
and, if feasible, either percutaneous or surgical revascular-
ization (8).
Clinical experience suggests that whereas some patients
with acute MI require longer hospital stays and more
extensive investigations, others could be safely discharged
earlier without invasive procedures. The only contemporary
randomized study of which we are aware, made a decade
ago, evaluated a three-day hospital stay for patients with
acute MI. However, all patients had undergone early coro-
nary arteriography and two-thirds had angioplasty (9).
Presumably because of the requirement for invasive strati-
fication, this study has not modified clinical practice in the
majority of patients with acute MI.
We undertook a randomized feasibility trial in patients
with acute MI, identified as being at low risk according to
simple and prospectively defined clinical criteria, comparing
a noninvasive three-day hospital stay strategy employing
24-h ambulatory electrocardiographic (ECG) ischemic
monitoring to usual clinical management. The psychosocial
impact, risk factor implications and follow-up outcomes of
this strategy were also assessed.
METHODS
Inclusion criteria. Between May 15, 1997, and Decem-
ber 1, 1998, all patients admitted to the Quebec Heart
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Institute/Laval Hospital, a tertiary care center, with a
diagnosis of acute MI were monitored by research nurses
using a checklist of eligibility criteria. The diagnosis of MI
required characteristic prolonged (at least 30 min) chest
pain or discomfort (or equivalent) with a creatine kinase
(CK) MB fraction $5% of total CK. Patients had to be
ambulatory by the 36th hour of presentation, not live alone
in the seven days following an eventual early discharge, be
reachable directly by telephone at home and not live more
than 30 min driving time from a hospital center where
thrombolysis could be performed.
Exclusion criteria. Patients were not considered candi-
dates for this short-stay strategy if they had any of the
following:
1. Cardiac catheterization during hospitalization or any
revascularization in the preceding six months.
2. Clinical evidence of cardiac failure or of moderate/severe
left ventricular dysfunction, defined as any of the follow-
ing: dyspnea, significant pulmonary rales, an abnormal
chest roentgenogram or a left ventricular ejection frac-
tion ,40% (all patients had an echocardiogram within
48 h).
3. Hemodynamic instability, defined as sustained hypoten-
sion (systolic pressure ,85 mm Hg at three intervals
separated by a minimum of 15 min) with the exception
of the very acute phase (first 6 to 12 h) of an inferior MI;
rapid and inappropriate resting heart rate (.90 beats/
min) more than 24 h after presentation, documented
over two consecutive hours; systolic blood pressure
$160 mm Hg and/or diastolic blood pressure
$90 mm Hg at three intervals separated by a minimum
of 15 min.
4. Cardiac ischemic symptoms .24 h following presenta-
tion or ST-segment depression or elevation $1 mm
(80 ms after the J-point) relative to baseline lasting
$1 min on the cardiac monitor or ECG.
5. Significant arrhythmia .24 h after presentation, defined
as ventricular fibrillation; sustained ventricular tachycar-
dia ($30 s); nonsustained repetitive ventricular tachycar-
dia; abnormally frequent, repetitive ectopic ventricular
beats (.60/h); sustained bradyarrhythmia (,40 beats/
min) except during sleep; ventricular pause $3 s; and in
general, any symptomatic arrhythmia.
6. Significant ECG abnormality, defined as complete left
bundle branch block (at any time, even transitory); new
or presumed new persistent complete right bundle
branch block; ventricular pacemaker-dependent rhythm;
any marked repolarization abnormality, reversible or
persistent .24 h after presentation, suggesting to the
clinician an important reversible ischemic substrate; any
persistent marked ST-segment depression (.1 mm)
rendering ST-segment analysis difficult; in case of an
anterior infarction any, even transitory, second- or third-
degree atrioventricular block; in case of an inferior
infarction, any daytime Mobitz type I block or second-
or third-degree block .24 h after admission.
7. Previous angina greater than Canadian Cardiovascular
Society class II.
8. Any condition that might prolong the patient’s hospi-
talization or render problematic an early discharge, such
as insufficient autonomy or comprehension, uncontrolled
diabetes, unstable or severe chronic obstructive pulmo-
nary disease, severe anemia, alcoholism or a psychiatric
disorder.
The study was approved by the hospital ethics committee
and all participating patients gave written informed consent.
Study procedure. With the accord of the attending physi-
cian, who accepted that patients randomized to short stay
would be discharged 24 h later in the absence of ischemia,
the study was proposed to patients who fulfilled the above
conditions at 48 h. After consent, patients were randomized
in a ratio of 2:1 to the short-stay strategy or the standard
stay using sealed envelopes and random numbers prepared
by the biostatistician. Standard-stay patients were managed
in the usual manner by the attending physician. Patients
randomized to the short-stay strategy had intravenous
medications such as nitrates and heparin stopped and
underwent three-channel 24-h ambulatory (Holter) ST-
monitoring (Series 8500 Marquette Holter Recorder, Mil-
waukee, Wisconsin). This equipment adheres to current
American College of Cardiology/American Heart Associa-
tion ST-monitoring guidelines (10). The monitor was
applied during daytime by experienced personnel trained in
ECG techniques. Control recordings were taken in reclin-
ing, sitting and standing positions and after hyperventila-
tion. Patients were encouraged to walk about the ward.
They descended and ascended two flights of stairs with a
nurse or physician while on the Holter monitor. If during
this 48 to 72 h phase, patients manifested ischemic symp-
toms or other exclusion criteria, the projected short stay was
cancelled and these patients reverted to usual care. During
this time, patients received counseling about MI and risk
factors.
At the completion of recording, the Holter data were fed
into the Marquette Tape Acquisition Unit and transferred
to the MARS Unity Workstation (Software Version 3.1,
1997) (Marquette Co., Milwaukee, Wisconsin). The tape
was analyzed during daytime by one of the study cardiolo-
gists. The three-channel recording was first examined in
trend mode and then scrutinized entirely beat-by-beat in
accelerated time. The display screen is highly interactive and
can be flexibly configured for amount and manner of tracing
display, magnification, printing and turnover speed. Opti-
mal reading can be performed with 1 min of three-channel
Abbreviations and Acronyms
CK 5 creatine kinase
ECG 5 electrocardiographic, electrocardiography
MI 5 myocardial infarction
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tracing displayed every second. An entire reading thus takes
approximately 20 to 25 min. The usual criteria of ischemic
positivity were applied, that is, $1 min of $1 mm sustained
ST-segment depression or elevation 80 ms after the J point
compared with baseline. No more than 1 mm baseline
ST-segment depression was permitted for eligibility to this
study because of the difficulty in interpreting a truly isch-
emic change in the presence of marked baseline ST-
segment depression. If there was baseline 1 mm ST-
depression, the criteria for ischemia required 1.5 mm
ST-depression from this baseline. A single ischemic episode
disqualified patients from early discharge and they then
reverted to usual care. Early discharge was also cancelled in
the event of a significant arrhythmia, as previously defined.
If the Holter reading was negative, patients were promptly
discharged.
Patients discharged early had 24-h access by telephone to
study personnel and were all contacted by telephone the day
after discharge. Patients were instructed not to engage in
more than light activity until the following week, when they
returned for a symptom-limited modified Bruce protocol
ECG treadmill exercise test and visits with the treating
cardiologist and a dietician. If exercise testing was not
feasible, dypridamole-thallium myocardial imaging was
substituted.
Patients were contacted at one and six months. Coronary
events (any death, myocardial reinfarction, unstable angina),
counting the most serious event per patient, were noted, as
was the cardiac-related rehospitalization rate. Unstable an-
gina was defined as prolonged (.5 min) ischemic symptoms
occurring at rest or minimal exertion and requiring rehos-
pitalization. Rates of coronary arteriography, angioplasty
and bypass surgery and the total number of these invasive
cardiac procedures in the two groups were noted. If coronary
arteriography and angioplasty were performed at the same
time, they were considered a single invasive procedure.
Follow-up exercise test results, lipid and diabetic status,
smoking habits and medications were also evaluated.
Psychosocial assessment. The psychosocial impact of the
short-stay strategy was assessed in the last 85 randomized
patients. In addition, we evaluated 30 consecutive nonran-
domized low-risk patients from another hospital to control
for institutional and study selection bias. This was a non-
tertiary center and the same selection criteria were used, but
these patients were unaware they were being identified as a
low-risk group and they had standard care. Psychosocial
outcomes were measured using: 1) the Beck Inventory,
assessing depression at discharge and at six months (11); 2)
Spielberger’s State-Trait Anxiety Inventory, a current state-
of-anxiety evaluation at hospital discharge (12); 3) the
Maeland and Havik Expectations Questionnaire, assessing
patients’ perception of loss of autonomy, physical capacity,
emotional control and work adequacy at discharge and one
month later (13); 4) the Maeland and Havik Cardiac
Knowledge Questionnaire, assessing comprehension of cor-
onary artery disease, at one month (13); and 5) Godin’s
Leisure Time Physical Activity Index, at one month (14).
Statistical analysis. In a preliminary pilot observation, we
found that the median hospital stay for 50 consecutive
patients with acute MI fulfilling these low-risk criteria was
6.3 days. Therefore, a sample size of 120 patients, with
randomization to a short-stay strategy or standard stay in a
2:1 ratio, would be necessary to show a 50% reduction in
total days hospitalized at six months with a power of 90%
and an alpha of 0.01. Because this was a low-risk group, it
was expected that the risk of death, reinfarction and
recurrent ischemia on six-month follow-up would be quite
low, so that an unrealistically large sample size would be
necessary to establish equivalence in terms of adverse clinical
events. Therefore, these were not end points, although they
were considered in the evaluation of the two approaches. All
analyses were on an intention-to-treat basis.
Values are expressed as means 6 standard deviations or
medians as appropriate. Data were analyzed using analysis
of variance. The Beck Depression Inventory and the Mae-
land and Havik Expectations Questionnaire were analyzed
with repeated measures using a two-way analysis of vari-
ance. The normality assumption was verified with the
Shapiro-Wilk test and Bartlett’s statistic was used to verify
homogeneity of variances. When normality and homogene-
ity of variances assumptions were not fulfilled, Wilcoxon’s
rank sum test was used. The Fisher exact test was used to
compare categorical variables. A p value #0.05 was consid-
ered statistically significant. The statistical package program
SAS was used (SAS Institute Inc., Cary, North Carolina).
RESULTS
During the study period, 525 patients admitted with an
acute MI were screened, and 120 patients (23%) were
randomized, 80 patients to the short-stay strategy and 40
patients to the standard stay. Numbers of patients excluded
and the reasons are shown in Figure 1. An analysis of these
exclusions showed that 94 patients (18% of all those
screened) had no a priori cardiac or other medical reason for
exclusion and would have been potentially eligible candi-
dates for the short-stay strategy. These were cases of patient
refusal, clinician’s reluctance, direct angioplasty or early
angiography without definite overriding indications for
these procedures and patients living alone or too far away. If
these patients are added to those randomized, 214 patients
or 41% of all screened patients with MI would have been
potential candidates for the short-stay strategy.
Mean age of the patients in this study was 56 6 9 years
and 85% were men. Clinical profiles and MI characteristics
of the short- and standard-stay arms were well balanced
(Table 1). In the study group as a whole, a Q-wave MI
occurred in 48 patients (40%); 56 patients (47%) underwent
thrombolysis. The presenting ECG showed ST-elevation in
67 patients (56%), ST-depression (and no ST elevation) in
10 patients (8%), and T-wave inversion only in 14 patients
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(12%). Myocardial infarction was anterior in 20 patients
(17%). Peak CK value was 1,234 6 1,181 U/L.
Of the 80 patients randomized to the short-stay strategy,
17 (21%) were not discharged at three days because of
ischemia on 48 to 72 h Holter monitoring in 11 patients
(symptomatic in one of these patients) and because of
angina with negative Holter findings in the other six
patients.
The median (and mean 6 standard deviations) duration
of initial hospitalization was halved from 6.9 (8.3 6 5.0)
days in the standard-stay group to 3.5 (4.9 6 3.8) days in
the short-stay group (p , 0.0001, Wilcoxon test). This
proportion was sustained when cumulative hospitalization
at six months was examined (7.5 [9.3 6 5.4] days compared
with 3.6 [6.0 6 4.9] days, respectively, p , 0.0001) (Fig. 2).
Before hospital discharge, one death occurred in the
standard-stay group within 24 h of coronary bypass surgery
in a patient with diabetes. This patient had painless isch-
emia on an exercise test of 7 metabolic equivalents and
coronary angiography showed three-vessel disease. One
small in-hospital reinfarction (peak CK ,300 U/L) oc-
curred in a short-stay patient before 72 h. Findings on
six-month follow-up are shown in Table 2. Adverse coro-
nary events after hospital discharge occurred in eight (10%)
short-stay and three (7.5%) standard-stay patients (p 5
NS). All of these were unstable angina episodes except for
one MI (peak CK ,200 U/L) occurring 11 days after
discharge in a short-stay patient. Median time to occurrence
of these events was more than one week after discharge in
both groups. There was a similar incidence of rehospital-
ization in the two groups. All patients who underwent
angioplasty had diagnostic coronary angiography at the
same time, thus counting as a single invasive procedure.
There were 25% fewer invasive cardiac procedures per-
formed in the short-stay arm (30 procedures in 80 patients)
than in the standard-stay arm (25 procedures in 40 pa-
Figure 1. Patients excluded and randomized during the study period. MI 5 myocardial infarction.
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tients). Intracoronary stents were used in 86% of the
short-stay and 90% of the standard-stay patients who had
angioplasty. Exercise test results and the proportion of tests
positive for ischemia were very similar in the two groups
(Table 2). Low density lipoprotein cholesterol levels on
follow-up were 2.9 6 0.8 mmol/L in the short-stay arm and
3.0 6 1.0 mmol/L in the standard-stay arm (p 5 0.6).
Table 1. Clinical and MI Characteristics in the Two
Patient Groups
Short-Stay
Strategy
(n 5 80)
Standard
Stay
(n 5 40)
Baseline Characteristics
Age (yr)* 56 6 10 57 6 8
Male gender 68 (85%) 34 (85%)
Current smokers 39 (49%) 19 (48%)
Ex-smokers 34 (43%) 14 (35%)
Hypertension 20 (25%) 7 (18%)
Diabetes mellitus 6 (8%) 5 (13%)
Hyperlipidemia 75 (94%) 37 (93%)
Previous MI 11 (14%) 6 (15%)
Previous angina 1 (1%) 2 (5%)
Previous coronary angioplasty 1 (1%) 1 (3%)
Previous bypass surgery 4 (5%) 1 (3%)
MI Characteristics
Q-wave 30 (38%) 18 (45%)
Thrombolysis 34 (43%) 22 (55%)
Anterior MI 15 (19%) 5 (13%)
ST elevation† 41 (51%) 26 (65%)
ST depression† 6 (8%) 4 (10%)
T-wave inversion† 9 (11%) 5 (13%)
Peak CK (U/L) 1,228 6 1,225 1,245 6 1,102
LV ejection fraction (%)* 57.4 6 6.8 56.8 6 7.4
*Plus-minus values are means 6 SD. † These abnormalities required at least 1 mm in
at least two contiguous leads. If more than one of these abnormalities was present,
only one was retained in the order in which they are listed. There were no significant
differences in any baseline or MI characteristics between the two groups.
CK 5 creatine kinase; LF 5 left ventricular; MI 5 myocardial infarction.
Figure 2. Initial hospital stay and total days hospitalized at six-month follow-up in the short-stay and standard-stay groups. Results are represented as
scatter plots with small squares indicating medians.
Table 2. Six-Month Follow-Up Data in the Two
Patient Groups
Short-Stay
Strategy
(n 5 80)
Standard
Stay
(n 5 40)
Events and Procedures
Death 0 1
Myocardial infarction 2 0
Unstable angina 7 (9%) 3 (8%)
Rehospitalization 12 (15%) 5 (13%)
Coronary angiography 26 (33%) 17 (43%)
Coronary angioplasty 14 (18%) 10 (25%)
Coronary bypass surgery 2 (3%) 3 (8%)
Invasive cardiac procedures* 30 25
Exercise METS (mean 6 SD) 10.0 6 2.5 10.3 6 2.0
Positive exercise tests† 32% 28%
Medications‡
Antiplatelet agents 76 (95%) 39 (100%)
Anticoagulants 4 (5%) 0
Beta-blockers 63 (79%) 31 (79%)
Calcium antagonists 7 (9%) 6 (15%)
Nitrates 6 (8%) 5 (13%)
Hypolipidemic agents 63 (79%) 36 (92%)
ACE inhibitors 9 (11%) 2 (5%)
*Invasive cardiac procedures include coronary angiography, angioplasty and bypass
surgery. The total number is counted in each group. Because angioplasty was always
performed at the same time as angiography, both are counted as a single procedure.
Two short-stay and five standard-stay patients had multiple percutaneous procedures.
†A positive test required 1 mm ST segment depression (1.5 mm if an ascending slope)
compared to baseline or unequivocal angina during exercise. ‡One in-hospital death
is excluded in these analyses. There were no significant differences in any of these
medications between the two groups.
ACE 5 angiotensin-coverting enzyme; METS 5 metabolic equivalent units.
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Proportions of smokers at the time of infarction who had
stopped smoking at six-month follow-up were 49% and
48% in the short- and standard-stay arms, respectively.
There were no significant differences in follow-up cardiac
medications between the two groups (Table 2).
There were no significant differences in any of the
psychosocial measures when short-stay patients were com-
pared with standard-stay patients and to nonrandomized
low-risk standard-stay patients from the second (nonter-
tiary) hospital. Moreover, serial measurements of psycho-
logical parameters in short-stay patients did not indicate
unfavorable repercussions at discharge or subsequently
(Table 3).
DISCUSSION
Previous studies. The clinical management of acute MI
has evolved considerably since Lewis advocated eight weeks
bed rest in 1937 (15). Twenty years ago, a one-week
hospital stay for uncomplicated MI was proposed after an
evaluation of 67 patients, half of whom were discharged at
one week (4). In 1986 to 1987, Topol et al. (9) randomized
80 patients to conventional (7 to 10 days) or early discharge
(three days) provided they had an “uncomplicated” MI and
a negative tomographic thallium exercise test. In addition,
nearly all patients had reperfusion therapy, all underwent
early cardiac catheterization and two-thirds had coronary
angioplasty. In similar vein, other studies have advocated
three- to four-day hospital stays for low-risk patients
stratified using coronary angiography and treated with
angioplasty (16,17). It is not surprising that such studies
have not changed general clinical practice because most
centers treating patients with MI do not have tertiary care
facilities and most patients probably do not need to undergo
invasive cardiac procedures for stratification and treatment
(18). Studies proposing a shorter hospital stay have also
been limited by retrospective design, absence of randomiza-
tion and restrictive definitions of qualifying MI (19–24).
Moreover, easily applicable criteria defining low-risk pa-
tients have been insufficiently developed, accounting for the
wide range of estimate of eligible patients for earlier
discharge (19–21,23,25). Unresolved questions, such as the
duration of heparin therapy and the role and safety of
exercise testing very early after MI, have also contributed to
a resistance to earlier discharge (26). Finally, the psycho-
social repercussions of a shorter hospitalization for acute MI
have been little explored. It has not been established
whether a shorter stay generates excessive insecurity and
anxiety with unfavorable consequences and increased read-
mission (27). Any study proposing a shorter hospitalization
should evaluate whether the reduction can be sustained on
follow-up.
The present study. This feasibility study addressed these
issues with a prospective and randomized design, a priori
consideration for study of all MI patients, an initially
noninvasive approach, a comparative psychosocial analysis
and use of ambulatory ST-segment ischemic monitoring
instead of exercise testing to permit early discharge. This is
the only recent and the largest such randomized study of
which we are aware.
Over the study period, 23% of all patients presenting with
an acute MI were randomized. More detailed analysis
showed that 41% would have been eligible for consideration
of such an approach. This is consistent with other studies
estimating the substantial proportion of low-risk patients
and justifies the strategy employed (19,23,25). Moreover,
the very low serious event rate in the study group supports
the pertinence of the relatively simple noninvasive criteria
used to identify such patients. The study not only shows
that a substantial and sustained reduction in days hospital-
ized is feasible but also suggests, contrary to previous
studies, that such an approach is not dependent on a greater
need for invasive cardiac procedures (9,16,17).
Psychosocial considerations. Myocardial infarction is an
important event in the life of an individual. It is frequently
the first indication of previously unsuspected coronary artery
disease and cannot but redefine a person’s prognosis, atti-
tudes and lifestyle. The psychosocial implications of this are
complex and profound and may themselves condition prog-
nosis (28–30). Because this matter is obviously more im-
portant than a question of days hospitalized, a caveat of this
study is that a short-stay approach must be associated with
a comprehensive approach to patient counseling and risk
factor education and the presence of an effectively support-
ive infrastructure. In such conditions, this study suggests
that a short-stay strategy is not accompanied by adverse
psychological consequences such as undue anxiety and
emotional distress. In addition, patient illness perception
Table 3. Psychosocial Assessment in the Short-Stay Strategy
and Two Control Groups*
Short-Stay
Strategy
(n 5 44)†
Control I
(n 5 25)†
Control II
(n 5 29)†
p
Value
Days hospitalized 3.3 6 0.3 7.9 6 4.1 9.0 6 5.7 0.001
BDI at discharge 4.6 6 7.4 3.2 6 3.9 4.3 6 5.3 0.8
BDI at six months‡ 4.1 6 4.9 4.0 6 4.2 4.9 6 5.8 0.8
STAI at discharge 33 6 10 30 6 8 33 6 10 0.4
FOR at discharge 105 6 13 105 6 14 103 6 10 0.8
FOR at one month‡ 105 6 13 102 6 16 100 6 13 0.3
KUN at one month 25 6 3 24 6 3 24 6 2 0.8
LTPAI at one month 16 (9–31) 21 (16–32) 16 (3–25) 0.3
*The control groups are: 1) the standard-stay group (Control I) and 2) the control
group from the other (nontertiary) hospital (Control II). Plus-minus values are means
6 SD. †Questionnaires were attempted in the last 85 patients of the main study
cohort and in 30 patients from the second hospital (Control II). Of the 56 potential
short-stay strategy questionnaires, three were incomplete and nine patients were
excluded because of angina/ischemia at 48 to 72 h; of the 29 potential standard–stay
questionnaires (Control I), one was incomplete and three patients were excluded
because of angina at 48 to 72 h; of the 30 control II questionnaires, one was excluded
because of angina at 48 to 72 h. To maintain intergroup comparability, questionnaires
were not attempted if there was angina/ischemia at 48 to 72 h because such short-stay
patients were not discharged early. ‡Results over time for BDI and FOR among the
three study groups did not differ significantly (p5 0.5 and p 5 0.7, respectively).
BDI 5 Beck Depression Inventory; FOR 5 Maeland and Havik Expectations
Questionnaire; KUN 5 Maeland and Havik Cardiac Knowledge Questionnaire;
LTPAI 5 Godin’s Leisure Time Physical Activity Index, expressed as median with
25% to 50% quartiles in parentheses; STAI 5 Spielberger’s State-Trait Anxiety
Inventory.
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and motivating lifestyle modifications do not appear unfa-
vorably affected.
Ambulatory ST-segment monitoring. An originality of
this study was the use of ambulatory ST-segment monitor-
ing for ischemia on days 2–3 in lieu of predischarge exercise
testing. This is attractive for several reasons. Such monitor-
ing is relatively easy to perform because it can be applied and
the data processed seven days a week by personnel already
available for obtaining hospital ECGs, and tracings can be
readily analyzed by clinicians trained in cardiac care. Early
exercise testing following MI might raise concerns about the
risks of unstable reactivation, unfavorable remodeling and
cardiac rupture, especially if exercise were symptom-limited
(26). As patients descended and ascended two flights of
stairs while on ST-segment monitoring, they in fact per-
formed the equivalent of a low-level exercise test. Above all,
use of ST-monitoring for ischemia is more an evaluation for
the presence of spontaneous myocardial ischemia than of
coronary artery reserve, which is more adequately the role of
the exercise test. Therefore, this technique appears more
appropriate for monitoring the activity of the unstable
plaque and might more confidently confirm stabilization of
the acute coronary syndrome. Indeed, this technique has
been shown to be a sensitive and specific indicator of risk
following an acute coronary event (31–33) and was recently
found superior to exercise testing in evaluating risk in
patients after MI (34).
Conclusions. We conclude that it is possible to identify an
important proportion of low-risk MI patients using nonin-
vasive easily applicable clinical criteria and it appears feasible
to discharge such patients at three days after negative
ambulatory 24-h ST-segment monitoring. Although these
findings must be tempered by the number of patients
studied, this approach does not appear to be associated with
adverse clinical consequences or unfavorable repercussions
on psychosocial rehabilitation. Compared with contempo-
rary clinical practice, this approach may result in fewer
invasive cardiac procedures while permitting a substantial
and sustained reduction in days hospitalized. More experi-
ence and perhaps a larger study may confirm the pertinence
of this new clinical management strategy for low-risk
patients with acute MI.
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